Results 161 to 170 of about 101,265 (243)

Plumbagin Disrupts Biofilm Integrity and Resistance Gene Expression in Carbapenem-Resistant <i>Acinetobacter baumannii</i>. [PDF]

J Microbiol Biotechnol
Youn MJ, Eom YB.
europepmc   +1 more source

Machine Learning in the ICU: Predicting Mortality in Patients with Carbapenem-Resistant Gram-Negative Bacilli Bloodstream Infections. [PDF]

J Intensive Care Med
Güler Ö, Alparslan V, İnner B, Balcı S, Düzgün A, Baykara N, Kuş A.   +6 more
europepmc   +1 more source

Successful treatment of carbapenem-resistant <i>Acinetobacter baumannii</i> and Enterobacterales coinfection with sulbactam-durlobactam combined with aztreonam: a case report. [PDF]

AME Case Rep
Yang S, Cheng Z, Liu Y, Ni L, Wei C.
europepmc   +1 more source

Temporal dynamics and predictors of carbapenem-resistant gram-negative bacteria in bloodstream infections in hematological patients. [PDF]

BMC Infect Dis
Sahin M, Mert A, Tosun AI, Yilmaz E, Bekoz HS, Kaynar L, Ceylan B.   +6 more
europepmc   +1 more source

Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD. [PDF]

Blood Adv
Fan C, Hayase T, Chang CC, Glover IK, Flores II, McDaniel LK, Ortega MR, Sanchez CA, El-Himri RK, Brown AN, Karmouch JL, Jamal MA, Ahmed SS, Halsey TM, Jin Y, Tsai WB, Prasad R, Enkhbayar A, Mohammed A, Schmiester M, Damania A, Ajami NJ, Wargo JA, Peterson CB, Rondon G, Al-Juhaishi T, Alousi AM, Molldrem JJ, Champlin RE, Shpall EJ, Martens E, Arias CA, Jenq RR, Hayase E.   +33 more
europepmc   +1 more source

Restriction Evaluation of Appropriate Carbapenem Therapy (REACT): A Multisite Observational Study. [PDF]

J Pharm Technol
Wells DA, McKnight M, Jaggar J, Cleveland KO, DeKerlegand A.   +4 more
europepmc   +1 more source

Erratum: Comparative in vitro Activity and Clinical Outcomes of Eravacycline, Tigecycline, and Omadacycline Against Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> [Corrigendum]. [PDF]

Infect Drug Resist
europepmc   +1 more source

Emergence of a carbapenem-resistant <i>Klebsiella pneumoniae</i> ST15-KL19 clone with elevated virulence potential in a tertiary hospital in China. [PDF]

Front Cell Infect Microbiol
Li G, Zhang Y, Ren G, Tian L, Jiao X, Sun L, Ren C.   +6 more
europepmc   +1 more source

Correction: Peptide-based antimicrobial effect against carbapenem-resistant <i>Acinetobacter baumannii</i>: preclinical drug assessment and translational potential. [PDF]

Front Pharmacol
Lee HJ, Lee SJ, Sung YH, Park SM, Choi SP, Kim Y, Yoon YK.   +6 more
europepmc   +1 more source

Therapeutic challenges and emerging strategies against carbapenem-resistant <i>Acinetobacter baumannii</i>. [PDF]

Curr Res Microb Sci
Yang C, Li J, Luo X, Song Z, Zhang J.
europepmc   +1 more source